-
1
-
-
0029864693
-
Report Of the. International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies
-
World Health Organization
-
Richardson P, McKennaW, Bristow M, Maisch B, Mautner B, O'Connell J et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841-842.
-
(1995)
Circulation
, vol.93
, pp. 841-842
-
-
Richardson, P.1
McKenna, W.2
Bristow, M.3
Maisch, B.4
Mautner, B.5
O'Connell, J.6
-
2
-
-
33646693410
-
Contemporary definitions and classification of the cardiomyopathies: An American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention
-
Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, ArnettDet al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-1816.
-
(2006)
Circulation
, vol.113
, pp. 1807-1816
-
-
Maron, B.J.1
Towbin, J.A.2
Thiene, G.3
Antzelevitch, C.4
Arnett, D.5
-
3
-
-
33750121615
-
Incidence, causes, and outcomes of dilated cardiomyopathy in children
-
Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867-1876.
-
(2006)
JAMA
, vol.296
, pp. 1867-1876
-
-
Towbin, J.A.1
Lowe, A.M.2
Colan, S.D.3
Sleeper, L.A.4
Orav, E.J.5
Clunie, S.6
-
4
-
-
79959741856
-
Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy: The cause of dilated cardiomyopathy: Genetic or acquired? (
-
Kimura A. Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy: the cause of dilated cardiomyopathy: genetic or acquired? (genetic-side). Circ J 2011;75:1756-1765.
-
(2011)
Genetic-side). Circ J
, vol.75
, pp. 1756-1765
-
-
Kimura, A.1
-
5
-
-
0037420074
-
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations
-
Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003;41:771-780.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 771-780
-
-
Taylor, M.R.1
Fain, P.R.2
Sinagra, G.3
Robinson, M.L.4
Robertson, A.D.5
Carniel, E.6
-
6
-
-
0037050022
-
The failing heart
-
Towbin JA, Bowles NE. The failing heart. Nature 2002;415:227-233.
-
(2002)
Nature
, vol.415
, pp. 227-233
-
-
Towbin, J.A.1
Bowles, N.E.2
-
7
-
-
84884489700
-
Genderspecific differences in major cardiac events and mortality in lamin A/C mutation carriers
-
van Rijsingen IA, Nannenberg EA, Arbustini E, Elliott PM, Mogensen J, Ast JF et al. Genderspecific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 2013;15:376-384.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 376-384
-
-
Van Rijsingen, I.A.1
Nannenberg, E.A.2
Arbustini, E.3
Elliott, P.M.4
Mogensen, J.5
Ast, J.F.6
-
8
-
-
3242808960
-
Gender modulates cardiac phenotype development in genetically modified mice
-
Du XJ. Gender modulates cardiac phenotype development in genetically modified mice. Cardiovasc Res 2004;63:510-519.
-
(2004)
Cardiovasc Res
, vol.63
, pp. 510-519
-
-
Du, X.J.1
-
9
-
-
0037084312
-
Estrogenic hormone action in the heart: Regulatory network and function
-
Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res 2002;53: 709-719.
-
(2002)
Cardiovasc Res
, vol.53
, pp. 709-719
-
-
Babiker, F.A.1
De Windt, L.J.2
Van Eickels, M.3
Grohe, C.4
Meyer, R.5
Doevendans, P.A.6
-
10
-
-
19944426537
-
Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies
-
ArimuraT, Helbling-Leclerc A, Massart C, Varnous S, Niel F, Lacene E et al. Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet 2005;14:155-169.
-
(2005)
Hum Mol Genet
, vol.14
, pp. 155-169
-
-
Arimura, T.1
Helbling-Leclerc, A.2
Massart, C.3
Varnous, S.4
Niel, F.5
Lacene, E.6
-
11
-
-
84856951638
-
DelK32-lamin A/C has abnormal location and induces incomplete tissue maturation and severe metabolic defects leading to premature death
-
Bertrand AT, Renou L, Papadopoulos A, Beuvin M, Lacene E, Massart C et al. DelK32-lamin A/C has abnormal location and induces incomplete tissue maturation and severe metabolic defects leading to premature death. Hum Mol Genet 2012;21:1037-1048.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 1037-1048
-
-
Bertrand, A.T.1
Renou, L.2
Papadopoulos, A.3
Beuvin, M.4
Lacene, E.5
Massart, C.6
-
12
-
-
10744223054
-
Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A
-
Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T et al. Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A. Endocrinology 2004;145:951-958.
-
(2004)
Endocrinology
, vol.145
, pp. 951-958
-
-
Li, Y.1
Kishimoto, I.2
Saito, Y.3
Harada, M.4
Kuwahara, K.5
Izumi, T.6
-
13
-
-
84866155998
-
Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-beta
-
Montalvo C, Villar AV, Merino D, Garcia R, Ares M, LlanoMet al. Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-beta. PLoS ONE 7:e35635.
-
PLoS ONE
, vol.7
, pp. e35635
-
-
Montalvo, C.1
Villar, A.V.2
Merino, D.3
Garcia, R.4
Ares, M.5
Llano, M.6
-
14
-
-
67650091283
-
Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy
-
Arimura T, Bos JM, Sato A, Kubo T, Okamoto H, Nishi H et al. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:334-342.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 334-342
-
-
Arimura, T.1
Bos, J.M.2
Sato, A.3
Kubo, T.4
Okamoto, H.5
Nishi, H.6
-
15
-
-
84859245840
-
-
Purevjav E, ArimuraT, Augustin S, HubyAC, Takagi K, Nunoda S et al. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.Hum Mol Genet 2012;21:2039-2053.
-
(2012)
Molecular Basis for Clinical Heterogeneity in Inherited Cardiomyopathies Due to Myopalladin Mutations.Hum Mol Genet
, vol.21
, pp. 2039-2053
-
-
Purevjav, E.1
Arimura, T.2
Augustin, S.3
Huby, A.C.4
Takagi, K.5
Nunoda, S.6
-
16
-
-
33746210029
-
Anti-androgenic activity of 3-methyl-4-nitrophenol in diesel exhaust particles
-
Li C, Taneda S, Suzuki AK, Furuta C, Watanabe G, Taya K. Anti-androgenic activity of 3-methyl-4-nitrophenol in diesel exhaust particles. Eur J Pharmacol 2006;543:194-199.
-
(2006)
Eur J Pharmacol
, vol.543
, pp. 194-199
-
-
Li, C.1
Taneda, S.2
Suzuki, A.K.3
Furuta, C.4
Watanabe, G.5
Taya, K.6
-
17
-
-
0026631505
-
ECGchanges under hyperkalemia with nephrectomy in the rat
-
Kuwahara M, Chiku K, ShionoT, Tsubone H, Sugano S.ECGchanges under hyperkalemia with nephrectomy in the rat. J Electrocardiol 1992;25:215-219.
-
(1992)
J Electrocardiol
, vol.25
, pp. 215-219
-
-
Kuwahara, M.1
Chiku, K.2
Shiono, T.3
Tsubone, H.4
Sugano, S.5
-
18
-
-
77949886788
-
Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model
-
Arimura T, Sato R, Machida N, Bando H, ZhanDY, Morimoto S et al. Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model. J Am Coll Cardiol 2010;55: 1503-1505.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1503-1505
-
-
Arimura, T.1
Sato, R.2
Machida, N.3
Bando, H.4
Zhan, D.Y.5
Morimoto, S.6
-
19
-
-
34248198298
-
Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy
-
Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, Bonne G et al. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest 2007;117:1282-1293.
-
(2007)
J Clin Invest
, vol.117
, pp. 1282-1293
-
-
Muchir, A.1
Pavlidis, P.2
Decostre, V.3
Herron, A.J.4
Arimura, T.5
Bonne, G.6
-
20
-
-
23644456010
-
SRF-dependent gene expression in isolated cardiomyocytes: Regulation of genes involved in cardiac hypertrophy
-
Nelson TJ, Balza R Jr, Xiao Q, Misra RP. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. J Mol Cell Cardiol 2005; 39:479-489.
-
(2005)
J Mol Cell Cardiol
, vol.39
, pp. 479-489
-
-
Nelson, T.J.1
Balza, R.2
Xiao, Q.3
Misra, R.P.4
-
22
-
-
65349121886
-
Genomics, transcriptional profiling, and heart failure
-
Margulies KB, Bednarik DP, Dries DL. Genomics, transcriptional profiling, and heart failure. J Am Coll Cardiol 2009;53:1752-1759.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1752-1759
-
-
Margulies, K.B.1
Bednarik, D.P.2
Dries, D.L.3
-
24
-
-
0041042154
-
FHL2, a novel tissuespecific coactivator of the androgen receptor
-
Muller JM, Isele U, Metzger E, Rempel A, Moser M, PschererA et al. FHL2, a novel tissuespecific coactivator of the androgen receptor. EMBO J 2000;19:359-369.
-
(2000)
EMBO J
, vol.19
, pp. 359-369
-
-
Muller, J.M.1
Isele, U.2
Metzger, E.3
Rempel, A.4
Pscherer, A.5
Moser, M.6
-
25
-
-
14844293101
-
Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene
-
Vlahopoulos S, ZimmerWE, Jenster G, Belaguli NS, Balk SP, BrinkmannAOet al. Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene. J Biol Chem 2005;280:7786-7792.
-
(2005)
J Biol Chem
, vol.280
, pp. 7786-7792
-
-
Vlahopoulos, S.1
Zimmer, W.E.2
Jenster, G.3
Belaguli, N.S.4
Balk, S.P.5
Brinkmann, A.O.6
-
26
-
-
0032515886
-
Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart
-
Chan KK, Tsui SK, Lee SM, Luk SC, Liew CC, Fung KP et al. Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene 1998;210:345-350.
-
(1998)
Gene
, vol.210
, pp. 345-350
-
-
Chan, K.K.1
Tsui, S.K.2
Lee, S.M.3
Luk, S.C.4
Liew, C.C.5
Fung, K.P.6
-
27
-
-
0030478367
-
Relation between gender, etiology and survival in patients with symptomatic heart failure
-
Adams KF Jr, Dunlap SH, Sueta CA, ClarkeSW, Patterson JH, Blauwet MB et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. JAmColl Cardiol 1996;28:1781-1788.
-
(1996)
JAmColl Cardiol
, vol.28
, pp. 1781-1788
-
-
Adams, K.F.1
Dunlap, S.H.2
Sueta, C.A.3
Clarke, S.W.4
Patterson, J.H.5
Blauwet, M.B.6
-
28
-
-
34250769956
-
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
-
O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Pina IL, Granger CB et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007;115:3111-3120.
-
(2007)
Circulation
, vol.115
, pp. 3111-3120
-
-
O'Meara, E.1
Clayton, T.2
McEntegart, M.B.3
McMurray, J.J.4
Pina, I.L.5
Granger, C.B.6
-
29
-
-
10744220461
-
Hormone replacement therapy is associated with improved survival inwomenwith advanced heart failure
-
Lindenfeld J, Ghali JK, Krause-Steinrauf HJ, Khan S, Adams K, Goldman S et al. Hormone replacement therapy is associated with improved survival inwomenwith advanced heart failure. J Am Coll Cardiol 2003;42:1238-1245.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 1238-1245
-
-
Lindenfeld, J.1
Ghali, J.K.2
Krause-Steinrauf, H.J.3
Khan, S.4
Adams, K.5
Goldman, S.6
-
30
-
-
0042922479
-
Sex hormones and cardiomyopathic phenotype induced by cardiac beta 2-adrenergic receptor overexpression
-
Gao XM, Agrotis A, Autelitano DJ, Percy E, Woodcock EA, Jennings GL et al. Sex hormones and cardiomyopathic phenotype induced by cardiac beta 2-adrenergic receptor overexpression. Endocrinology 2003;144:4097-4105.
-
(2003)
Endocrinology
, vol.144
, pp. 4097-4105
-
-
Gao, X.M.1
Agrotis, A.2
Autelitano, D.J.3
Percy, E.4
Woodcock, E.A.5
Jennings, G.L.6
-
31
-
-
84864297656
-
Testosterone supplementation in heart failure: A meta-analysis
-
Toma M, McAlister FA, Coglianese EE, Vidi V, Vasaiwala S, Bakal JA et al. Testosterone supplementation in heart failure: a meta-analysis. Circ Heart Fail 2012;5:315-321.
-
(2012)
Circ Heart Fail
, vol.5
, pp. 315-321
-
-
Toma, M.1
McAlister, F.A.2
Coglianese, E.E.3
Vidi, V.4
Vasaiwala, S.5
Bakal, J.A.6
|